Risk Management - AI & Automation - Safety Vigilance

Mariette Boerstoel-Streefland, MD, MBA, MSc(epi), has been in the pharmaceutical industry for 35 years, and is currently SVP, Worldwide Patient Safety Officer at BMS. Mariette joined pharma industry from clinical practice in 1989 and held various leadership positions in drug safety at Organon (now ...

Aysha Amman is a senior Pharmacovigilance leader with 15+ years of pharmaceutical experience, overseeing Global PV Operations, PV Compliance, and REMS Operations with expertise in regulatory compliance, safety governance, and Risk Management Programs.She is recognized for building strong governance ...

Juhaeri is an Epidemiologist with over thirty years of experience in epidemiologic research in academia and in the pharmaceutical industry. He has built and developed various teams at Sanofi, including Epidemiology, Signal Detection, Benefit – Risk Evaluation and Global Safety Sciences, brought and ...

William Blumentals has spent over 20 years supporting and leading epidemiology teams in biopharma, including roles with increasing responsibility in pharmacovigilance and medical affairs.  In addition, he has been an author on over 40 peer-reviewed publications.  Currently, William is the Head of...

Shefali Jobanputra works at Takeda, where she supports global patient safety compliance, process improvement, and training initiatives. She is passionate about advancing patient safety through practical solutions, collaboration, and continuous learning. She enjoys connecting with professionals...

Reema Mehta, PharmD, MPH is Vice President, Head of Risk Assessment & Management (RAM) at Pfizer Inc., where she leads the strategic integration of risk assessment across the product lifecycle, including risk communication, minimization strategies, signal detection and management, safety data...

Michael von Forstner is a seasoned pharma/biotech executive with over 25 years of experience in drug development with a focus on strategic patient safety and pharmacovigilance. As the Chief Scientific Officer at MedGenie, he is responsible for the development of innovative digital health solutions...

Viny Srinivasan is a seasoned professional with extensive experience in the field of patient safety and risk management. Currently serving as the Head of Global Market Vigilance for Beauty & Wellbeing at Unilever, Viny brings a wealth of knowledge and expertise across Pharma, Consumer...

Dr. Aristizabal is Medical Doctor graduated from the National University of Colombia, with additional studies in Business Administration and  Patient Safety. For the past twuelve years she has served as Medical Director at Vitalis, where she has focused her work on research and development of...

Bill Kivett is a seasoned professional with a passion for driving innovation and excellence in patient safety through technology and performance optimization. As the Director of Product Management at Clarivate Analytics. Bill brings a wealth of experience in developing cutting-edge solutions that...

Dr. Tony P. Nguyen is the US Patient Safety & Pharmacovigilance Country Head at Novartis, based in East Hanover, NJ. In his current role, Tony leads the development and implementation of local US pharmacovigilance strategies, oversees safety policies and procedures to ensure regulatory...

Jason Ancell, MBA, PMP, serves as Director, Benefit-Risk Science & Process at Gilead Sciences, where he leads and supports global risk management initiatives designed to enhance patient safety and ensure regulatory compliance. With more than 18 years of experience in U.S. REMS and global risk...

Dr. Tarik Messaoud is a physician, international pharmacovigilance consultant, advisor, and speaker who regularly contributes to major drug safety congresses across North America and Europe. He holds a Graduate Diploma in Clinical Research and Clinical Trial Management from the Université de...

Kal Elhoregy, RPh., PA, is a senior pharmaceutical industry consultant with more than 25 years of experience leading global Risk Management, Pharmacovigilance (PV) Compliance, and PV Quality Governance across multinational organizations. He is recognized for developing enterprise governance models...

Victoria Bartasek is a dedicated and accomplished Senior Associate Director in Patient Safety and Pharmacovigilance, currently leading a team in US Operations at Boehringer Ingelheim Pharma GmbH & Co. KG. With over 26 years of experience in the pharmaceutical industry, Victoria is a seasoned...

Dr. Mudassar Iqbal Arain is a researcher in clinical research, pharmacovigilance, and patient safety, currently affiliated as Clinical Assistant Professor with the University of North Carolina Wilmington (UNCW). His research focuses on adverse drug reaction (ADR) reporting, patient engagement in...

As Vice President of US Operations Francois is responsible for driving business transformation programs, sales, deliveries and customer engagement. Francois expertise is embedded in enterprise change management, cross-cultural integration, process re-engineering, and pharmacovigilance. He has...

Raghavendra Parvataraju is an enterprise AI innovator and the Founder and CEO of Graph AI Services Inc. (Graph Safety). Recognized as an architect of global scale, he is a GTM and P&L leader who has built and scaled multi-billion-dollar enterprise technology businesses while leading business...

Timothy Roe leads M2D Global Life Sciences, a specialized consulting and advisory firm serving biopharmaceutical organizations across all stages of clinical development. With deep expertise in pharmacovigilance governance, regulatory strategy, and outsourcing models, Timothy advises senior...

Aman Wasan is the CEO of ArisGlobal. Aman is a Scientist by training with a degree in Human Genomics. He has a deep knowledge of the Life Sciences industry, a well-established background in global leadership roles, and an expert in operational management and commercial leadership.Prior to taking...

Dr. Layo Emmanuel is a distinguished Global Patient Safety Physician and executive trainer based in the United States, specializing in lifecycle pharmacovigilance, signal management, and proactive risk mitigation infrastructure. Operating at the intersection of clinical excellence and strategic...

Ann-Marie brings more than 30 years of expertise to the ArisGlobal team and as CIO plays a pivotal role in driving the company’s technological development, fostering a results-driven culture, advising on the best solutions to stay ahead of the competition, optimizing processes, and capitalizing on...

Vasudev Bhupathi, MS, is a Global Director of Pharmacovigilance at Moderna, based in Cambridge, Massachusetts, with nearly two decades of leadership experience in clinical safety and pharmacovigilance across vaccines, infectious diseases, oncology, neurology, and other complex therapeutic areas. He ...

Joann Evangelista is a distinguished pharmaceutical leader, renowned for her expertise in drug safety, quality assurance, and operational innovation. In her current role in Quality Assurance, she leads the development of country-level quality strategies to ensure confidence in the Quality...

Jacqueline Gerena is a pharmaceutical leader with expertise in risk management, regulatory compliance, and cross-functional leadership. She currently serves as the Director of Risk Management Strategy at Johnson & Johnson, leading a team at the forefront of developing innovative approaches for...

Dr. Karthik Babu is a Pharmacovigilance (PV) expert with a clinical background and over two decades of experience spanning clinical research and global pharmacovigilance operations. He holds a Bachelor of Ayurvedic Medicine and Surgery (BAMS) and an Executive MBA from the Indian Institute of...

Michelle Motta Dardeno is a senior biopharmaceutical executive with more than 25 years of experience across global pharmacovigilance, patient safety, compliance, and operations. She currently serves as Vice President, Global Pharmacovigilance Excellence at Nuvalent, where she leads strategies and...

Dr. Nandini Devi Akurathi, MD, is a Drug Safety Physician and Regulatory Affairs professional with over eight years of experience leading global pharmacovigilance, safety surveillance, signal management, risk mitigation, and regulatory compliance activities across clinical development and...

Joy Haugh, BSN, Senior Director and Safety Lead in Global Pharmacovigilance at Sarepta Therapeutics. Joy is a pharmacovigilance and drug safety leader with nearly 20 years of experience spanning biotechnology, pharmaceuticals, and rare disease drug development. She has held leadership roles across...

Mayra Moura Oliveira is a registered nurse with a PhD in Collective Health and 19 years of experience in immunization. She currently serves as Pharmacovigilance Manager at Instituto Butantan and as a Director of the Brazilian Society of Immunizations (SBIm). Her work focuses on vaccine...

Nina Teo is a dedicated and experienced Senior Manager in Safety & Risk Management at Alnylam Pharmaceuticals, where she leads and supports pharmacovigilance and risk management activities across clinical development and marketed products. With extensive experience in drug safety, risk...

Ercem Atillasoy, MD has 30 years of experience leading product development and more than 25 years within Regulatory Affairs, Clinical Safety, and Quality-related functional areas. He currently serves as the Chief Regulatory and Safety Officer (CRSO) and Senior Vice President, Research and...

Marie A. Liles-Burden, MPH, is a pharmacovigilance and risk management leader with more than 15 years of experience in global drug safety, benefit-risk assessment, and regulatory risk management. She currently serves as Director of Pharmacovigilance Risk Management at Takeda, where she provides...

Dr. Hayashi is the Associate Director of DILI within the Division of Hepatology and Nutrition, FDA.  He received his Bachelor of Arts in microbiology at UCLA and MD at University of California (UC), San Diego.  After completing residency and gastroenterology fellowship at UC Davis in...

Lucas Phillips is the Acting Head of Vigilance Development at the UK Medicines and Healthcare products Regulatory Agency (MHRA). Since joining the Agency in 2021, he has held leadership roles across signal assessment, adverse incident management, vigilance operations, and system development. He has ...